LACTOCOCCUS LACTIS PRODUCING TSLP OR IL-25 AND THEIR USES AS PROBIOTICS AND THERAPEUTICS

USPTO Patent Application US 2018/0104285 A1
Application Date: Apr. 19th, 2018

ABSTRACT

The present invention relates to recombinant Lactococcus lactis bacteria expressing and secreting TSLP or IL-25 or a combination thereof, and their use as probiotics or therapeutic agents, especially for use...
Application Number:
15/565,958
International Classification:
A61K 35/744 (20060101); C07K 14/54 (20060101); C07K 14/52 (20060101); A61K 38/20 (20060101); A61K 38/19 (20060101); A61K 45/06 (20060101); A61P 29/00 (20060101); A61P 1/00 (20060101); A61P 1/04 (20060101); A61P 37/02 (20060101); A23L 33/135 (20060101); A23L 33/00 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

1-15. (canceled)

DESCRIPTION

FIELD OF THE INVENTION

The present application relates to the microbiology and medicine field. More particularly, it relates to a recombinant bacterium producing a cytokine for use as therapeutics, in particular as anti-inflammatory agent.
Back to Top